Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN55334531
ISRCTN55334531
Completed
Not Applicable

Optimum platelet inhibition after coronary artery bypass surgery: a prospective, randomised trial comparing platelet aggregation using low- and medium-dose aspirin and clopidogrel

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites108 target enrollmentSeptember 12, 2003
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCoronary artery bypass grafting (CABG)Surgery

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary artery bypass grafting (CABG)
Sponsor
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Enrollment
108
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2003
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • •72 Patients and 36 controls will be recruited from patients proceeding to coronary artery bypass surgery.

Exclusion Criteria

  • •Does not match inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Coronary intervention and optimal AntiPlatelet Therapy-Optical coherence tomography study
JPRN-UMIN000013719Osaka General Medical Center200
Active, not recruiting
Phase 1
DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial InjuryStable coronary artery disease.MedDRA version: 17.0 Level: PT Classification code 10011078 Term: Coronary artery disease System Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2014-000952-26-GBniversity of Edinburgh202
Active, not recruiting
Phase 1
Treatment with medications that prevent the formation of blood clots, in the primary prevention of heart disease in patients with a stable lung condition called Chronic Obstructive Pulmonary Disease (COPD).
EUCTR2014-005475-86-GBThe Newcastle upon Tyne Hospitals NHS Foundation Trust120
Active, not recruiting
Not Applicable
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGESubjects who present with an acute coronary syndrome.MedDRA version: 12.0Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: PTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: LLTClassification code 10006894Term: CABG
EUCTR2008-001135-35-CZThe Medicines Company220
Active, not recruiting
Not Applicable
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGE
EUCTR2008-001135-35-GBThe Medicines Company220